Rheumatology International

, Volume 28, Issue 5, pp 401–406 | Cite as

Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behcet’s disease etiopathogenesis

  • Sule Yavuz
  • Yesim Elbir
  • Aysin Tulunay
  • Emel Eksioglu-Demiralp
  • Haner Direskeneli
Original Article


The objective of this study was to investigate the expressions of toll-like receptors on neutrophils and monocytes in Behcet’s disease (BD). Forty-two patients with BD were included in the study. Baseline and stimulated cells with heat shock protein-60 (HSP-60), lipopolysaccharide (LPS) and crude extract of Streptococcus sanguis (SS) were analyzed for toll-like receptor-1, -2, -4 and -6 expressions using flow cytometer. Results were confirmed using semi-quantitative PCR technique. The mean frequency of TLR-6 expressing granulocytes in BD patients was significantly lower than in controls (4.2 ± 0.6 vs. 9.2 ± 0.6 and 8.0 ± 1.4, BD vs. rheumatoid arthritis (RA) and healthy control (HC); P < 0.05). TLR-6 expressing granulocyte population was enhanced after stimulation with HSP-60 and SS (20 ± 0.5 and 12.8 ± 0.6, respectively). Decreased TLR-2 expression was noted in monocytes of BD patients after stimulation with HSP-60 and LPS (71.0 ± 0.5 and 73.0 ± 0.5; P < 0.02, for both antigens). Functional abnormalities of these receptors or different activation cascades by different microorganisms are associated with disease pathogenesis in Behcet’s disease.


Behcet’s disease Innate immunity cells Toll-like receptors 


  1. 1.
    Yazici H, Yurdakul S, Hamuryudan V (1998) Behcet’s syndrome. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, London, 7:26:1–6Google Scholar
  2. 2.
    Mumcu G, Inanc N, Yavuz S, Direskeneli H (2007). The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behcet’s disease. Clin Exp Rheumatol, Sept. 2007 SupplementGoogle Scholar
  3. 3.
    Lehner T, Lavery E, Smith R et al (1991) Association between the 65 kDa heat shock protein, Streptoccocus sanguis and the corresponding antibodies in Behcet’s syndrome. Infect Immun 59:1434–1441PubMedGoogle Scholar
  4. 4.
    Mumcu G, Ergun T, Inanc N et al (2004) Oral health is impaired in Behcet’s disease and associated with disease severity. Rheumatology 43:1028–1033PubMedCrossRefGoogle Scholar
  5. 5.
    Direskeneli H, Eksioglu-Demiralp E, Yavuz S, Ergun T, Lehner T, Akoglu T (2000) T cell responses to 60/65 kDa HSP derived peptides in Turkish Behcet’s disease patients. J Rheum 27:708–713PubMedGoogle Scholar
  6. 6.
    Miura T, Ishihara K, Kato T et al (2005) Detection of heat shock proteins but not superantigen by isolated oral bacteria from patients with Behcet’s disease. Oral Microbial Immunol 20:167–171CrossRefGoogle Scholar
  7. 7.
    Kol A, Lichtman AH, Finberg RW, Libby P, Kurt-Jones EA (2000) Heat shock protein 60 activates the innate immune response: CD14 is an essential receptor for HSP-60 activation of mononuclear cells. J Immunol 164:13–17PubMedGoogle Scholar
  8. 8.
    Chen W, Syldath U, Bellman K, Burkart V, Kolb H (1999) Human 60-kDa Heat shock protein: a danger signal to the innate immune system. J Immunol 162:3212–3219PubMedGoogle Scholar
  9. 9.
    Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335–376PubMedCrossRefGoogle Scholar
  10. 10.
    Henneke P, Morath S, Uematsu S et al (2005) Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J Immunol 174:6449–6455PubMedGoogle Scholar
  11. 11.
    Takeuchi O, Kawai T, Muhiracht PF et al (2001) Discrimination of bacterial lipoproteins by toll-like receptor 6. Int Immunol 13:933–940PubMedCrossRefGoogle Scholar
  12. 12.
    International study group for Behcet’s disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080Google Scholar
  13. 13.
    Nakao Y, Funami K, Kikkawa S et al (2005) Surface-expressed TLR-6 participates in the recognition of diacylated lipopeptide and peptidolgycan in human cells. J Immunol 174:1566–1573PubMedGoogle Scholar
  14. 14.
    Omueti KO, Beyer JM, Johnson CN, Lyle EA, Tapping RI (2005) Domain exchange between human toll-like receptors 1and 6 reveals a region required for lipopeptide discrimination. J Biol Chem 280:36616–36625PubMedCrossRefGoogle Scholar
  15. 15.
    Iwahashi M, Yamamura M, Aita T et al (2004) Expression of toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 50:1457–1467PubMedCrossRefGoogle Scholar
  16. 16.
    Kawanaka N, Yamamura M, Aita T et al (2002) CD14 + CD16 + blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum 46:2578–2586PubMedCrossRefGoogle Scholar
  17. 17.
    Belge KU, Dayyani F, Horelt A et al (2002) The proinflammatory CD14 + CD16 + DR++ monocytes are a major source of TNF. J Immunol 168:3536–3542PubMedGoogle Scholar
  18. 18.
    Sahin S, Lawrence R, Direskeneli H, Hamuryudan V, Yazici H, Akoglu T (1996) Monocyte activity in Behcet’s disease. Br J Rheum 35:424–429CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Sule Yavuz
    • 1
    • 3
  • Yesim Elbir
    • 2
  • Aysin Tulunay
    • 2
  • Emel Eksioglu-Demiralp
    • 2
  • Haner Direskeneli
    • 1
  1. 1.Department of RheumatologyUniversity of MarmaraIstanbulTurkey
  2. 2.Department of Haematology–ImmunologyUniversity of MarmaraIstanbulTurkey
  3. 3.IstanbulTurkey

Personalised recommendations